Literature DB >> 3008673

Monoclonal antibody B72.3 as a diagnostic adjunct in fine needle aspirates of breast masses.

J Lundy, M Lozowski, Y Mishriki.   

Abstract

Fine needle aspirations of breast masses were evaluated to establish a cytologic diagnosis. In 45 cases, the sensitivity was 73%, specificity 100%, and diagnostic accuracy 84%. Fifty cases (27 malignant and 23 benign) were evaluated by immunoperoxidase staining of the needle aspirates, using the monoclonal antibody B72.3. Twenty-six of 27 malignant cases stained positively, and 22 of 23 benign cases were negative. The sensitivity was 96%, specificity was 96%, and diagnostic accuracy was 96%. All cases considered malignant cytologically were confirmed by immunocytochemistry. In addition, the B72.3 monoclonal antibody appears to be a valuable diagnostic adjunct in atypical and suspicious cases, particularly those in which hypocellularity and/or cellular monomorphism preclude a diagnosis of malignancy by routine cytologic examination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008673      PMCID: PMC1251124          DOI: 10.1097/00000658-198604000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Changing concepts in establishing the diagnosis of breast masses.

Authors:  M R Coates; Y H Pilch; J R Benfield
Journal:  Am J Surg       Date:  1977-07       Impact factor: 2.565

2.  Fine needle aspiration cytology of the breast. A review of 321 cases with statistical evaluation.

Authors:  N J Wollenberg; J G Caya; L J Clowry
Journal:  Acta Cytol       Date:  1985 May-Jun       Impact factor: 2.319

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  The value of aspiration cytology in the diagnosis of breast cancer: experience at the Fondation Curie.

Authors:  A Zajdela; N A Ghossein; J P Pilleron; A Ennuyer
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

5.  Masquerades of malignancy: a review of 4,241 aspirates from the breast.

Authors:  T S Kline
Journal:  Acta Cytol       Date:  1981 May-Jun       Impact factor: 2.319

6.  Cytologic findings of aspiration of tumors of the breast.

Authors:  J E Russ; D P Winchester; E F Scanlon; M A Christ
Journal:  Surg Gynecol Obstet       Date:  1978-03

7.  Aspiration cytology is superior to Tru-Cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses.

Authors:  M M Shabot; I M Goldberg; P Schick; R Nieberg; Y H Pilch
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

8.  A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.

Authors:  M Nuti; Y A Teramoto; R Mariani-Costantini; P H Hand; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

9.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Accuracy of breast cancer diagnosis by physical, radiologic and cytologic combined examinations.

Authors:  A Azzarelli; A Guzzon; S Pilotti; V Quagliuolo; A Bono; S Di Pietro
Journal:  Tumori       Date:  1983-04-30
View more
  2 in total

1.  Monoclonal antibody B72.3 in benign breast lesions.

Authors:  S Soomro; S Shousha
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Immunocytochemistry with monoclonal antibody B72.3 applied to a spectrum of benign and malignant breast aspirates--strengths and pitfalls.

Authors:  J Lundy; M Lozowski; Y Mishriki
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.